SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-055623
Filing Date
2022-02-28
Accepted
2022-02-28 06:10:54
Documents
9
Period of Report
2022-02-28

Document Format Files

Seq Description Document Type Size
1 6-K d69418d6k.htm 6-K 10127
2 EX-99.1 d69418dex991.htm EX-99.1 322377
3 GRAPHIC g69418g04a55.jpg GRAPHIC 16982
4 GRAPHIC g69418g05s66.jpg GRAPHIC 10818
5 GRAPHIC g69418g08s51.jpg GRAPHIC 641227
6 GRAPHIC g69418g09a22.jpg GRAPHIC 528821
7 GRAPHIC g69418g35s66.jpg GRAPHIC 34851
8 GRAPHIC g69418g43b83.jpg GRAPHIC 7296
9 GRAPHIC g69418g48v28.jpg GRAPHIC 1835
  Complete submission text file 0001193125-22-055623.txt   2038218
Mailing Address LEVEL 4 650 CHAPEL STREET SOUTH YARRA, VICTORIA C3 3141
Business Address LEVEL 4 650 CHAPEL STREET SOUTH YARRA, VICTORIA C3 3141 61 3 9826 0399
Opthea Ltd (Filer) CIK: 0001815620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-39621 | Film No.: 22683773
SIC: 2836 Biological Products, (No Diagnostic Substances)